These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17094342)

  • 21. Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence.
    Parekh BS; Kennedy MS; Dobbs T; Pau CP; Byers R; Green T; Hu DJ; Vanichseni S; Young NL; Choopanya K; Mastro TD; McDougal JS
    AIDS Res Hum Retroviruses; 2002 Mar; 18(4):295-307. PubMed ID: 11860677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Re: "Confidence intervals for biomarker-based human immunodeficiency virus incidence estimates and differences using prevalent data".
    Cole SR; Chu H
    Am J Epidemiol; 2007 Oct; 166(7):861-2. PubMed ID: 17709327
    [No Abstract]   [Full Text] [Related]  

  • 23. Validation of a method to estimate age-specific human immunodeficiency virus (HIV) incidence rates in developing countries using population-based seroprevalence data.
    Saidel T; Sokal D; Rice J; Buzingo T; Hassig S
    Am J Epidemiol; 1996 Aug; 144(3):214-23. PubMed ID: 8686690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV infection in men who have sex with men, New York City Department of Health sexually transmitted disease clinics, 1990-1999: a decade of serosurveillance finds that racial disparities and associations between HIV and gonorrhea persist.
    Torian LV; Makki HA; Menzies IB; Murrill CS; Weisfuse IB
    Sex Transm Dis; 2002 Feb; 29(2):73-8. PubMed ID: 11818891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV-1 incidence estimates using IgG-capture BED-enzyme immunoassay from surveillance sites of injection drug users in three cities of China.
    Jiang Y; Wang M; Ni M; Duan S; Wang Y; Feng J; Xiao Y; Dong Y; Wang D; Han M; Xiang L; Ma L; Zhou Q
    AIDS; 2007 Dec; 21 Suppl 8():S47-51. PubMed ID: 18172391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Highly specific V3 peptide enzyme immunoassay for serotyping HIV-1 specimens from Thailand.
    Pau CP; Lee-Thomas S; Auwanit W; George JR; Ou CY; Parekh BS; Granade TC; Holloman DL; Phillips S; Schochetman G
    AIDS; 1993 Mar; 7(3):337-40. PubMed ID: 8471195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Multispot EIA with Western blot for confirmatory serodiagnosis of HIV.
    Torian LV; Forgione LA; Punsalang AE; Pirillo RE; Oleszko WR
    J Clin Virol; 2011 Dec; 52 Suppl 1():S41-4. PubMed ID: 21995935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the false recent classification rates of multiassay algorithms in estimating HIV type 1 subtype C incidence.
    Moyo S; LeCuyer T; Wang R; Gaseitsiwe S; Weng J; Musonda R; Bussmann H; Mine M; Engelbrecht S; Makhema J; Marlink R; Baum MK; Novitsky V; Essex M
    AIDS Res Hum Retroviruses; 2014 Jan; 30(1):29-36. PubMed ID: 23937344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of prospective and cross-sectional measures of HIV type 1 incidence in a higher-risk cohort in Ho Chi Minh City, Vietnam.
    Sexton CJ; Costenbader EC; Vinh DT; Chen PL; Hoang TV; Lan NT; Feldblum P; Kim A; Giang le T
    AIDS Res Hum Retroviruses; 2012 Aug; 28(8):866-73. PubMed ID: 21936716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accurate detection of maternal antibodies to HIV in newborn whole blood dried on filter paper.
    Pappaioanou M; Kashamuka M; Behets F; Mbala S; Biyela K; Davachi F; George JR; Green TA; Dondero TJ; Heyward WL
    AIDS; 1993 Apr; 7(4):483-8. PubMed ID: 8507414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunologic marker paths for seroconversion: single determinations of immunoglobulin A and beta 2-microglobulin are not adequate to estimate time of HIV infection. Multicohort Analysis Project Workshop. Part II.
    AIDS; 1994 Jul; 8(7):923-33. PubMed ID: 7946101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maturity of human immunodeficiency virus infection and incubation period of acquired immunodeficiency syndrome in injecting drug users.
    Alcabes P; Muñoz A; Vlahov D; Friedland G
    Ann Epidemiol; 1994 Jan; 4(1):17-26. PubMed ID: 7911376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors.
    Busch MP; Lee LL; Satten GA; Henrard DR; Farzadegan H; Nelson KE; Read S; Dodd RY; Petersen LR
    Transfusion; 1995 Feb; 35(2):91-7. PubMed ID: 7825218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the sensitivity of four rapid assays for the detection of antibodies to HIV-1/HIV-2 during seroconversion.
    Samdal HH; Gutigard BG; Labay D; Wiik SI; Skaug K; Skar AG
    Clin Diagn Virol; 1996 Oct; 7(1):55-61. PubMed ID: 9077430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low estimates of HIV seroconversions among clients of a drug treatment clinic in San Francisco, 1995 to 1998.
    McFarland W; Kellogg TA; Louie B; Murrill C; Katz MH
    J Acquir Immune Defic Syndr; 2000 Apr; 23(5):426-9. PubMed ID: 10866236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concordance of PCR and antibody results from HIV testing of injecting drug users.
    Kral AH; Watters JK; Lifson AR; Carlson JR; Stanley M
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Nov; 10(3):381-5. PubMed ID: 7552501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and Evaluation of a Modified Fourth-Generation Human Immunodeficiency Virus Enzyme Immunoassay for Cross-Sectional Incidence Estimation in Clade B Populations.
    Kirkpatrick AR; Patel EU; Celum CL; Moore RD; Blankson JN; Mehta SH; Kirk GD; Margolick JB; Quinn TC; Eshleman SH; Laeyendecker O
    AIDS Res Hum Retroviruses; 2016 Aug; 32(8):756-62. PubMed ID: 26988426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001.
    Des Jarlais DC; Perlis T; Arasteh K; Torian LV; Hagan H; Beatrice S; Smith L; Wethers J; Milliken J; Mildvan D; Yancovitz S; Friedman SR
    AIDS; 2005 Oct; 19 Suppl 3():S20-5. PubMed ID: 16251819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-1 incidence determined retrospectively among drug users in Bangkok, Thailand.
    Kitayaporn D; Uneklabh C; Weniger BG; Lohsomboon P; Kaewkungwal J; Morgan WM; Uneklabh T
    AIDS; 1994 Oct; 8(10):1443-50. PubMed ID: 7818815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of the sensitive/less-sensitive (detuned) EIA strategy for targeting genetic analysis of HIV-1 to recently infected blood donors.
    Machado DM; Delwart EL; Diaz RS; de Oliveira CF; Alves K; Rawal BD; Sullivan M; Gwinn M; Clark KA; Busch MP
    AIDS; 2002 Jan; 16(1):113-9. PubMed ID: 11741169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.